Endoscopic evaluation of surgically altered bowel in inflammatory bowel disease: a consensus guideline from the Global Interventional Inflammatory Bowel Disease Group

. 2021 Jun ; 6 (6) : 482-497. [epub] 20210417

Jazyk angličtina Země Nizozemsko Médium print-electronic

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid33872568
Odkazy

PubMed 33872568
DOI 10.1016/s2468-1253(20)30394-0
PII: S2468-1253(20)30394-0
Knihovny.cz E-zdroje

The majority of patients with Crohn's disease and a proportion of patients with ulcerative colitis will ultimately require surgical treatment despite advances in diagnosis, therapy, and endoscopic interventions. The surgical procedures that are most commonly done include bowel resection with anastomosis, strictureplasty, faecal diversion, and ileal pouch. These surgical treatment modalities result in substantial alterations in bowel anatomy. In patients with inflammatory bowel disease, endoscopy plays a key role in the assessment of disease activity, disease recurrence, treatment response, dysplasia surveillance, and delivery of endoscopic therapy. Endoscopic evaluation and management of surgically altered bowel can be challenging. This consensus guideline delineates anatomical landmarks and endoscopic assessment of these landmarks in diseased and surgically altered bowel.

Center for Advanced IBD Research and Treatment Kitasato University Kitasato Institute Hospital Tokyo Japan

Center for Inflammatory Bowel Disease Department of Gastroenterology The 2nd Affiliated Hospital of Zhejiang University School of Medicine Hangzhou China

Center for Inflammatory Bowel Disease Virginia Mason Clinic Seattle WA USA

Center for Interventional Inflammatory Bowel Disease Columbia University Irving Medical Center New York Presbyterian Hospital NY USA

Clinical and Research Centre for Inflammatory Bowel Disease Clinical Centre ISCARE Prague Czech Republic

Clinical and Research Centre for Inflammatory Bowel Disease ISCARE Clinical Centre Prague Czech Republic

Department of Gastroenterology and Hepatology Cleveland Clinic Florida Weston FL USA

Department of Gastroenterology Dayanand Medical College and Hospital Ludhiāna Punjab India

Department of Gastroenterology Henry Ford Hospital Detroit MI USA

Department of Gastroenterology Hospital Ceske Budejovice Ceske Budejovice Czech Republic

Department of Gastroenterology Hospital Universitari Mútua Terrassa Fundació per la Recerca Mútua Terrassa Terrassa Catalonia; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Madrid Spain

Department of Gastroenterology Mayo Clinic Jacksonville Jacksonville FL USA

Department of Gastroenterology Mayo Clinic Rochester MN USA

Department of Gastroenterology The 1st Affiliated Hospital of Sun Yat sen University Guangzhou China

Department of Gastroenterology University of California San Diego San Diego CA USA

Department of Gastroenterology Vanderbilt University Medical Center Nashville TN USA

Department of Pathology Immunology and Laboratory Medicine University of Florida Gainsville FL USA

Division of Colorectal Surgery Columbia University Irving Medical Center New York Presbyterian Hospital NY USA

Division of Gastroenterology and Hepatology Tufts Medical Center Boston MA USA

Division of Gastroenterology Hepatology and Nutrition Allegheny Health Network Pittsburgh PA USA

Division of Gastroenterology University of Mississippi Medical Center Jackson MS USA

Division of Pediatric Gastroenterology Columbia University Irving Medical Center New York Presbyterian Hospital NY USA

Gastroenterology Department Instituto Clínic de Enfermedades Digestivas y Metabólicas Hospital Clínic de Barcelona Barcelona Spain

IBD Center and IBD Interventional Unit Digestive Health Institute Orlando Health Orlando FL USA

IBD Outpatients Clinic Catholic University of Paraná Curitiba Brazil

IBD Unit Gastroenterology and Hepatology Department Hospital Universitario Puerta de Hierro Madrid Spain

Inflammatory Bowel Disease Clinical and Research Centre University of Manitoba Winnipeg MB Canada

Inflammatory Bowel Disease Program University of Maryland School of Medicine Maryland MD USA

Institute of Immunology and Immunotherapy NIHR Birmingham Biomedical Research Centre University Hospitals NHS Foundation Trust University of Birmingham UK

Mount Sinai Hospital Inflammatory Bowel Disease Centre Toronto ON Canada

San Francisco Veterans Affairs Medical Center and Department of Gastroenterology University of California San Francisco CA USA

Erratum v

PubMed

Komentář v

PubMed

Komentář v

PubMed

Citace poskytuje Crossref.org

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...